Xeris Biopharma Holdings, Inc. Balance Sheet

Balance Sheet Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Assets
Current Assets
Cash & Equivalents 37.60M67.27M121.97M67.45M71.62M
Short-term Investments 96.19M35.16M5.00M
Cash & Current Investments 133.79M102.43M121.97M72.45M71.62M
Receivables - Net 6.88M17.46M30.83M39.20M40.41M
Receivables 6.88M17.46M30.83M39.20M40.41M
Inventory 8.35M18.12M24.73M38.84M48.17M
Prepaid Assets 3.20M4.59M9.29M5.78M7.45M
Current Assets 152.21M142.60M186.82M156.26M167.66M
Non-Current Assets
Property, Plant & Equipment (Net) 6.71M6.63M5.52M5.97M5.56M
Long-Term Investments 96.19M
Goodwill 22.86M22.86M22.86M22.86M
Intangibles 131.45M120.61M109.76M98.92M
Goodwill & Intangibles 154.31M143.47M132.62M121.78M
Other Non-Current Assets 0.23M0.83M4.73M4.54M5.41M
Non-Current Assets 6.94M161.76M157.70M166.34M155.40M
Assets 159.15M304.36M344.52M322.60M323.06M
Liabilities
Current Liabilities
Accounts Payables 3.12M8.92M4.61M11.56M2.29M
Payables 3.12M8.92M4.61M11.56M2.29M
Accumulated Expenses 15.89M49.09M36.79M23.51M27.72M
Other Accumulated Expenses 5.98M15.04M16.82M22.15M29.08M
Short term Debt 19.11M15.10M
Current Leases 1.58M3.50M6.08M
Total Current Liabilities 28.21M79.04M73.62M95.19M100.44M
Non-Current Liabilities
Non-Current Debt 190.93M217.01M
Non-Current Deffered Revenue 6.63M6.88M
Non-Current Deferred Tax Liability 0.44M5.31M3.63M20.46M6.09M
Operating Leases 9.40M34.76M33.26M
Other Non-Current Liabilities 3.53M22.53M25.69M4.85M1.97M
Total Non-Current Liabilities 121.86M186.60M273.65M324.54M350.71M
Total Liabilities 125.39M209.13M299.33M329.38M352.68M
Shareholder's Equity
Total Debt 210.04M232.11M
Common Equity 33.76M95.23M45.19M-6.78M-29.61M
Shareholder's Equity 33.76M95.23M45.19M-6.78M-29.61M
Liabilities and Shareholders Equity 159.15M304.36M344.52M322.60M323.06M
Retained Earnings -337.38M-460.11M-554.77M-617.02M-671.86M
Treasury Shares 0.77M5.26M11.58M16.42M